Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Eli Lilly initiated with an Equal Weight at Wells Fargo » 16:35
12/08/21
12/08
16:35
12/08/21
16:35
LLY

Eli Lilly

$244.28 /

-0.77 (-0.31%)

Wells Fargo analyst Mohit…

Wells Fargo analyst Mohit Bansal initiated coverage of Eli Lilly with an Equal Weight rating and $270 price target. The company has a "solid growth business and clean story otherwise," but its Alzheimer's prospects will likely dominate 2022, Bansal tells investors in a research note. The analyst says that according to his experts, early approval of donanemab would be less important long term. This, coupled with Eli Lilly's valuation, keeps him on the sidelines.

ShowHide Related Items >><<
LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

LLY Eli Lilly
$244.28 /

-0.77 (-0.31%)

Conference/Events
SABCS to hold a symposium » 04:55
12/08/21
12/08
04:55
12/08/21
04:55
AZN

AstraZeneca

$54.79 /

-0.625 (-1.13%)

, BYSI

BeyondSpring

$4.67 /

+0.575 (+14.06%)

, CHRS

Coherus Biosciences

$17.95 /

+0.33 (+1.87%)

, CNTX

Context Therapeutics

$5.51 /

-0.08 (-1.43%)

, DSNKY

Daiichi Sankyo

$24.24 /

+0.535 (+2.26%)

, ESALY

Eisai

$60.56 /

-0.11 (-0.18%)

, EXAS

Exact Sciences

$83.51 /

+2.61 (+3.23%)

, GILD

Gilead

$69.68 /

+0.18 (+0.26%)

, GH

Guardant Health

$95.44 /

+6.8 (+7.67%)

, INCY

Incyte

$66.74 /

+1.73 (+2.66%)

, JAGX

Jaguar Health

$1.32 /

+0.155 (+13.30%)

, LLY

Eli Lilly

$245.03 /

-1.165 (-0.47%)

, MGNX

MacroGenics

$17.18 /

+0.46 (+2.75%)

, MRK

Merck

$72.27 /

-1.15 (-1.57%)

, MYGN

Myriad Genetics

$26.06 /

+1.07 (+4.28%)

, NTRA

Natera

$92.59 /

+6.45 (+7.49%)

, NEO

NeoGenomics

$33.92 /

+2.33 (+7.38%)

, NVS

Novartis

$80.70 /

+0.18 (+0.22%)

, OLMA

Olema Oncology

$11.02 /

+0.52 (+4.95%)

, OCX

OncoCyte

$2.40 /

+0.09 (+3.90%)

, ONCY

Oncolytics

$1.67 /

+0.06 (+3.73%)

, PBYI

Puma Biotechnology

$3.08 /

+0.11 (+3.70%)

, PFE

Pfizer

$51.72 /

+0.22 (+0.43%)

, RHHBY

Roche

$49.77 /

+0.04 (+0.08%)

, SNY

Sanofi

$47.91 /

+0.34 (+0.71%)

, SGEN

Seagen

$146.46 /

+0.435 (+0.30%)

, SPPI

Spectrum

$1.54 /

+0.17 (+12.41%)

, VCYT

Veracyte

$41.21 /

+3.66 (+9.75%)

, VERU

Veru

$6.36 /

+0.175 (+2.83%)

, VTRS

Viatris

$12.40 /

-0.04 (-0.32%)

, ZYME

Zymeworks

$18.26 /

+0.025 (+0.14%)

San Antonio Breast Cancer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$18.26 /

+0.025 (+0.14%)

VTRS Viatris
$12.40 /

-0.04 (-0.32%)

VERU Veru
$6.36 /

+0.175 (+2.83%)

VCYT Veracyte
$41.21 /

+3.66 (+9.75%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.91 /

+0.34 (+0.71%)

SGEN Seagen
$146.46 /

+0.435 (+0.30%)

RHHBY Roche
$49.77 /

+0.04 (+0.08%)

PFE Pfizer
$51.72 /

+0.22 (+0.43%)

PBYI Puma Biotechnology
$3.08 /

+0.11 (+3.70%)

ONCY Oncolytics
$1.67 /

+0.06 (+3.73%)

OLMA Olema Oncology
$11.02 /

+0.52 (+4.95%)

OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

NVS Novartis
$80.70 /

+0.18 (+0.22%)

NTRA Natera
$92.59 /

+6.45 (+7.49%)

NEO NeoGenomics
$33.92 /

+2.33 (+7.38%)

MYGN Myriad Genetics
$26.06 /

+1.07 (+4.28%)

MRK Merck
$72.27 /

-1.15 (-1.57%)

MGNX MacroGenics
$17.18 /

+0.46 (+2.75%)

LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

JAGX Jaguar Health
$1.32 /

+0.155 (+13.30%)

INCY Incyte
$66.74 /

+1.73 (+2.66%)

GILD Gilead
$69.68 /

+0.18 (+0.26%)

GH Guardant Health
$95.44 /

+6.8 (+7.67%)

EXAS Exact Sciences
$83.51 /

+2.61 (+3.23%)

ESALY Eisai
$60.56 /

-0.11 (-0.18%)

DSNKY Daiichi Sankyo
$24.24 /

+0.535 (+2.26%)

CNTX Context Therapeutics
$5.51 /

-0.08 (-1.43%)

CHRS Coherus Biosciences
$17.95 /

+0.33 (+1.87%)

BYSI BeyondSpring
$4.67 /

+0.575 (+14.06%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

12/07/21 Jefferies
AstraZeneca downgraded to Hold from Buy at Jefferies
12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
BYSI BeyondSpring
$4.67 /

+0.575 (+14.06%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
CHRS Coherus Biosciences
$17.95 /

+0.33 (+1.87%)

11/09/21 H.C. Wainwright
Coherus Biosciences price target lowered to $30 from $36 at H.C. Wainwright
07/23/21 H.C. Wainwright
Coherus Biosciences price target raised to $36 from $26 at H.C. Wainwright
05/17/21 Barclays
Coherus Biosciences price target lowered to $24 from $28 at Barclays
05/07/21 H.C. Wainwright
Coherus Biosciences price target lowered to $26 from $28 at H.C. Wainwright
CNTX Context Therapeutics
$5.51 /

-0.08 (-1.43%)

DSNKY Daiichi Sankyo
$24.24 /

+0.535 (+2.26%)

10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
03/15/21 Citi
Citi opens 'positive catalyst watch' on Daiichi Sankyo
03/08/21 Goldman Sachs
Daiichi Sankyo upgraded to Buy from Neutral at Goldman Sachs
ESALY Eisai
$60.56 /

-0.11 (-0.18%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
EXAS Exact Sciences
$83.51 /

+2.61 (+3.23%)

11/03/21 BTIG
Exact Sciences price target lowered to $120 from $145 at BTIG
11/03/21 Craig-Hallum
Exact Sciences price target lowered to $133 from $144 at Craig-Hallum
11/03/21 Raymond James
Exact Sciences downgraded to Outperform from Strong Buy at Raymond James
11/03/21 Wells Fargo
Exact Sciences price target lowered to $95 from $120 at Wells Fargo
GILD Gilead
$69.68 /

+0.18 (+0.26%)

12/07/21 Piper Sandler
Gilead's lenacapavir opportunity remains intact, says Piper Sandler
12/06/21 Goldman Sachs
Gilead initiated with a Neutral at Goldman Sachs
11/19/21 Barclays
Arcus Biosciences price target raised to $60 from $48 at Barclays
11/18/21 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
GH Guardant Health
$95.44 /

+6.8 (+7.67%)

10/14/21 Cowen
Guardant Health coverage transferred at Cowen
08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
INCY Incyte
$66.74 /

+1.73 (+2.66%)

11/18/21 BMO Capital
Incyte initiated with a Market Perform at BMO Capital
10/15/21 Cantor Fitzgerald
Incyte price target lowered to $79 from $104 at Cantor Fitzgerald
10/04/21 Truist
Incyte price target lowered to $95 from $120 at Truist
09/28/21 B. Riley
Syndax collaboration 'significant vote of confidence,' says B. Riley
JAGX Jaguar Health
$1.32 /

+0.155 (+13.30%)

07/07/21
Fly Intel: Top five analyst initiations
07/07/21 Cantor Fitzgerald
Jaguar Health initiated with an Overweight at Cantor Fitzgerald
02/24/21 Ladenburg
Jaguar Health transferred with Buy, $3.75 target at Ladenburg
LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
MGNX MacroGenics
$17.18 /

+0.46 (+2.75%)

11/17/21 Guggenheim
MacroGenics assumed with a Buy at Guggenheim
10/19/21 JMP Securities
MacroGenics initiated with an Outperform at JMP Securities
10/14/21 BTIG
MacroGenics assumed with a Buy at BTIG
06/07/21 Wedbush
MacroGenics price target lowered to $34 from $39 at Wedbush
MRK Merck
$72.27 /

-1.15 (-1.57%)

12/07/21
Fly Intel: Top five analyst downgrades
12/07/21 Guggenheim
Guggenheim downgrades Merck on Keytruda concentration, low pipeline visibility
12/07/21 Guggenheim
Merck downgraded to Neutral from Buy at Guggenheim
11/29/21
Fly Intel: Top five analyst downgrades
MYGN Myriad Genetics
$26.06 /

+1.07 (+4.28%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NTRA Natera
$92.59 /

+6.45 (+7.49%)

11/05/21 Baird
Natera price target raised to $152 from $145 at Baird
10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
NEO NeoGenomics
$33.92 /

+2.33 (+7.38%)

12/07/21 Needham
NeoGenomics price target lowered to $41 from $48 at Needham
11/05/21 Morgan Stanley
Morgan Stanley downgrades NeoGenomics, sees limited near-term upside
11/05/21 Morgan Stanley
NeoGenomics downgraded to Equal Weight from Overweight at Morgan Stanley
10/14/21 Raymond James
NeoGenomics upgraded to Outperform from Market Perform at Raymond James
NVS Novartis
$80.70 /

+0.18 (+0.22%)

12/06/21 Exane BNP Paribas
Novartis downgraded to Neutral from Outperform at Exane BNP Paribas
12/03/21
Fly Intel: Top five analyst downgrades
12/03/21 Bryan Garnier
Novartis downgraded to Neutral on pipeline concerns at Bryan Garnier
12/03/21 Bryan Garnier
Novartis downgraded to Neutral from Buy at Bryan Garnier
OLMA Olema Oncology
$11.02 /

+0.52 (+4.95%)

12/06/21 Cowen
Olema Oncology assumed with an Outperform at Cowen
12/06/21 Cowen
Olema Oncology assumed with an Outperform at Cowen
10/11/21
Olema Oncology participates in a conference call with JPMorgan
05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
ONCY Oncolytics
$1.67 /

+0.06 (+3.73%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
PBYI Puma Biotechnology
$3.08 /

+0.11 (+3.70%)

09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
12/24/20 Craig-Hallum
Celcuity price target raised to $19 from $16 at Craig-Hallum
PFE Pfizer
$51.72 /

+0.22 (+0.43%)

12/06/21 BofA
BioNTech price target raised to $349 from $341 at BofA
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
RHHBY Roche
$49.77 /

+0.04 (+0.08%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
SNY Sanofi
$47.91 /

+0.34 (+0.71%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SGEN Seagen
$146.46 /

+0.435 (+0.30%)

11/08/21 Wolfe Research
Seagen initiated with a Peer Perform at Wolfe Research
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
VCYT Veracyte
$41.21 /

+3.66 (+9.75%)

11/18/21 Goldman Sachs
Veracyte reinstated with a Buy at Goldman Sachs
11/10/21 Raymond James
Veracyte price target raised to $62 from $50 at Raymond James
06/28/21 Raymond James
Veracyte price target raised to $50 from $45 at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
VERU Veru
$6.36 /

+0.175 (+2.83%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VTRS Viatris
$12.40 /

-0.04 (-0.32%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
ZYME Zymeworks
$18.26 /

+0.025 (+0.14%)

11/17/21 Guggenheim
Zymeworks assumed with a Neutral at Guggenheim
10/06/21 Jefferies
Zymeworks initiated with a Hold at Jefferies
09/13/21 Raymond James
Zymeworks data continue to outperform Herceptin, says Raymond James
08/05/21 H.C. Wainwright
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright
ZYME Zymeworks
$18.26 /

+0.025 (+0.14%)

VTRS Viatris
$12.40 /

-0.04 (-0.32%)

VERU Veru
$6.36 /

+0.175 (+2.83%)

VCYT Veracyte
$41.21 /

+3.66 (+9.75%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.91 /

+0.34 (+0.71%)

SGEN Seagen
$146.46 /

+0.435 (+0.30%)

RHHBY Roche
$49.77 /

+0.04 (+0.08%)

PFE Pfizer
$51.72 /

+0.22 (+0.43%)

PBYI Puma Biotechnology
$3.08 /

+0.11 (+3.70%)

ONCY Oncolytics
$1.67 /

+0.06 (+3.73%)

OCX OncoCyte
$2.40 /

+0.09 (+3.90%)

NVS Novartis
$80.70 /

+0.18 (+0.22%)

NTRA Natera
$92.59 /

+6.45 (+7.49%)

MYGN Myriad Genetics
$26.06 /

+1.07 (+4.28%)

MRK Merck
$72.27 /

-1.15 (-1.57%)

MGNX MacroGenics
$17.18 /

+0.46 (+2.75%)

LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

INCY Incyte
$66.74 /

+1.73 (+2.66%)

GILD Gilead
$69.68 /

+0.18 (+0.26%)

GH Guardant Health
$95.44 /

+6.8 (+7.67%)

EXAS Exact Sciences
$83.51 /

+2.61 (+3.23%)

BYSI BeyondSpring
$4.67 /

+0.575 (+14.06%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

  • 22
    Jul
  • 20
    Oct
  • 18
    Feb
  • 05
    Feb
  • 05
    Feb
  • 07
    Jan
ZYME Zymeworks
$18.26 /

+0.025 (+0.14%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.91 /

+0.34 (+0.71%)

RHHBY Roche
$49.77 /

+0.04 (+0.08%)

PFE Pfizer
$51.72 /

+0.22 (+0.43%)

NVS Novartis
$80.70 /

+0.18 (+0.22%)

NEO NeoGenomics
$33.92 /

+2.33 (+7.38%)

MRK Merck
$72.27 /

-1.15 (-1.57%)

LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

GILD Gilead
$69.68 /

+0.18 (+0.26%)

GH Guardant Health
$95.44 /

+6.8 (+7.67%)

EXAS Exact Sciences
$83.51 /

+2.61 (+3.23%)

ESALY Eisai
$60.56 /

-0.11 (-0.18%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

ZYME Zymeworks
$18.26 /

+0.025 (+0.14%)

VCYT Veracyte
$41.21 /

+3.66 (+9.75%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.91 /

+0.34 (+0.71%)

SGEN Seagen
$146.46 /

+0.435 (+0.30%)

RHHBY Roche
$49.77 /

+0.04 (+0.08%)

PFE Pfizer
$51.72 /

+0.22 (+0.43%)

PBYI Puma Biotechnology
$3.08 /

+0.11 (+3.70%)

OLMA Olema Oncology
$11.02 /

+0.52 (+4.95%)

NVS Novartis
$80.70 /

+0.18 (+0.22%)

NTRA Natera
$92.59 /

+6.45 (+7.49%)

NEO NeoGenomics
$33.92 /

+2.33 (+7.38%)

MRK Merck
$72.27 /

-1.15 (-1.57%)

MGNX MacroGenics
$17.18 /

+0.46 (+2.75%)

LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

JAGX Jaguar Health
$1.32 /

+0.155 (+13.30%)

INCY Incyte
$66.74 /

+1.73 (+2.66%)

GILD Gilead
$69.68 /

+0.18 (+0.26%)

GH Guardant Health
$95.44 /

+6.8 (+7.67%)

EXAS Exact Sciences
$83.51 /

+2.61 (+3.23%)

CNTX Context Therapeutics
$5.51 /

-0.08 (-1.43%)

BYSI BeyondSpring
$4.67 /

+0.575 (+14.06%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

VTRS Viatris
$12.40 /

-0.04 (-0.32%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

PFE Pfizer
$51.72 /

+0.22 (+0.43%)

NVS Novartis
$80.70 /

+0.18 (+0.22%)

MRK Merck
$72.27 /

-1.15 (-1.57%)

LLY Eli Lilly
$245.03 /

-1.165 (-0.47%)

INCY Incyte
$66.74 /

+1.73 (+2.66%)

GILD Gilead
$69.68 /

+0.18 (+0.26%)

BYSI BeyondSpring
$4.67 /

+0.575 (+14.06%)

AZN AstraZeneca
$54.79 /

-0.625 (-1.13%)

Tuesday
Conference/Events
SABCS to hold a symposium » 10:22
12/07/21
12/07
10:22
12/07/21
10:22
AZN

AstraZeneca

$53.65 /

-1.76 (-3.18%)

, BYSI

BeyondSpring

$4.59 /

+0.5 (+12.22%)

, CHRS

Coherus Biosciences

$17.68 /

+0.06 (+0.34%)

, CNTX

Context Therapeutics

$5.63 /

+0.04 (+0.72%)

, DSNKY

Daiichi Sankyo

$23.70 /

-1.46 (-5.80%)

, ESALY

Eisai

$60.67 /

+0.47 (+0.78%)

, EXAS

Exact Sciences

$83.65 /

+2.75 (+3.40%)

, GILD

Gilead

$69.06 /

-0.44 (-0.63%)

, GH

Guardant Health

$94.94 /

+6.3 (+7.11%)

, INCY

Incyte

$66.58 /

+1.57 (+2.42%)

, JAGX

Jaguar Health

$1.23 /

+0.065 (+5.58%)

, LLY

Eli Lilly

$243.25 /

-2.945 (-1.20%)

, MGNX

MacroGenics

$17.22 /

+0.5 (+2.99%)

, MRK

Merck

$72.16 /

-1.26 (-1.72%)

, MYGN

Myriad Genetics

$26.16 /

+1.17 (+4.68%)

, NTRA

Natera

$92.20 /

+6.06 (+7.04%)

, NEO

NeoGenomics

$34.37 /

+2.78 (+8.80%)

, NVS

Novartis

$80.49 /

-0.03 (-0.04%)

, OLMA

Olema Oncology

$11.28 /

+0.78 (+7.43%)

, OCX

OncoCyte

$2.42 /

+0.11 (+4.76%)

, ONCY

Oncolytics

$1.68 /

+0.07 (+4.35%)

, PBYI

Puma Biotechnology

$3.00 /

+0.03 (+1.01%)

, PFE

Pfizer

$51.75 /

+0.25 (+0.49%)

, RHHBY

Roche

$49.73 /

+0.38 (+0.77%)

, SNY

Sanofi

$47.51 /

-0.06 (-0.13%)

, SGEN

Seagen

$148.08 /

+2.06 (+1.41%)

, SPPI

Spectrum

$1.54 /

+0.17 (+12.41%)

, VCYT

Veracyte

$40.67 /

+3.12 (+8.31%)

, VERU

Veru

$6.32 /

+0.14 (+2.27%)

, VTRS

Viatris

$12.50 /

+0.065 (+0.52%)

, ZYME

Zymeworks

$18.97 /

+0.735 (+4.03%)

San Antonio Breast Cancer…

San Antonio Breast Cancer Symposium: SABCS 2021 to be held on December 7-10. Webcast Link

ShowHide Related Items >><<
ZYME Zymeworks
$18.97 /

+0.735 (+4.03%)

VTRS Viatris
$12.50 /

+0.065 (+0.52%)

VERU Veru
$6.32 /

+0.14 (+2.27%)

VCYT Veracyte
$40.67 /

+3.12 (+8.31%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.51 /

-0.06 (-0.13%)

SGEN Seagen
$148.08 /

+2.06 (+1.41%)

RHHBY Roche
$49.73 /

+0.38 (+0.77%)

PFE Pfizer
$51.75 /

+0.25 (+0.49%)

PBYI Puma Biotechnology
$3.00 /

+0.03 (+1.01%)

ONCY Oncolytics
$1.68 /

+0.07 (+4.35%)

OLMA Olema Oncology
$11.28 /

+0.78 (+7.43%)

OCX OncoCyte
$2.42 /

+0.11 (+4.76%)

NVS Novartis
$80.49 /

-0.03 (-0.04%)

NTRA Natera
$92.20 /

+6.06 (+7.04%)

NEO NeoGenomics
$34.37 /

+2.78 (+8.80%)

MYGN Myriad Genetics
$26.16 /

+1.17 (+4.68%)

MRK Merck
$72.16 /

-1.26 (-1.72%)

MGNX MacroGenics
$17.22 /

+0.5 (+2.99%)

LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

JAGX Jaguar Health
$1.23 /

+0.065 (+5.58%)

INCY Incyte
$66.58 /

+1.57 (+2.42%)

GILD Gilead
$69.06 /

-0.44 (-0.63%)

GH Guardant Health
$94.94 /

+6.3 (+7.11%)

EXAS Exact Sciences
$83.65 /

+2.75 (+3.40%)

ESALY Eisai
$60.67 /

+0.47 (+0.78%)

DSNKY Daiichi Sankyo
$23.70 /

-1.46 (-5.80%)

CNTX Context Therapeutics
$5.63 /

+0.04 (+0.72%)

CHRS Coherus Biosciences
$17.68 /

+0.06 (+0.34%)

BYSI BeyondSpring
$4.59 /

+0.5 (+12.22%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

12/07/21 Jefferies
AstraZeneca downgraded to Hold from Buy at Jefferies
12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
BYSI BeyondSpring
$4.59 /

+0.5 (+12.22%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
CHRS Coherus Biosciences
$17.68 /

+0.06 (+0.34%)

11/09/21 H.C. Wainwright
Coherus Biosciences price target lowered to $30 from $36 at H.C. Wainwright
07/23/21 H.C. Wainwright
Coherus Biosciences price target raised to $36 from $26 at H.C. Wainwright
05/17/21 Barclays
Coherus Biosciences price target lowered to $24 from $28 at Barclays
05/07/21 H.C. Wainwright
Coherus Biosciences price target lowered to $26 from $28 at H.C. Wainwright
CNTX Context Therapeutics
$5.63 /

+0.04 (+0.72%)

DSNKY Daiichi Sankyo
$23.70 /

-1.46 (-5.80%)

10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
03/15/21 Citi
Citi opens 'positive catalyst watch' on Daiichi Sankyo
03/08/21 Goldman Sachs
Daiichi Sankyo upgraded to Buy from Neutral at Goldman Sachs
ESALY Eisai
$60.67 /

+0.47 (+0.78%)

10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
EXAS Exact Sciences
$83.65 /

+2.75 (+3.40%)

11/03/21 BTIG
Exact Sciences price target lowered to $120 from $145 at BTIG
11/03/21 Craig-Hallum
Exact Sciences price target lowered to $133 from $144 at Craig-Hallum
11/03/21 Raymond James
Exact Sciences downgraded to Outperform from Strong Buy at Raymond James
11/03/21 Wells Fargo
Exact Sciences price target lowered to $95 from $120 at Wells Fargo
GILD Gilead
$69.06 /

-0.44 (-0.63%)

12/07/21 Piper Sandler
Gilead's lenacapavir opportunity remains intact, says Piper Sandler
12/06/21 Goldman Sachs
Gilead initiated with a Neutral at Goldman Sachs
11/19/21 Barclays
Arcus Biosciences price target raised to $60 from $48 at Barclays
11/18/21 BMO Capital
Gilead upgraded to Outperform from Market Perform at BMO Capital
GH Guardant Health
$94.94 /

+6.3 (+7.11%)

10/14/21 Cowen
Guardant Health coverage transferred at Cowen
08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
INCY Incyte
$66.58 /

+1.57 (+2.42%)

11/18/21 BMO Capital
Incyte initiated with a Market Perform at BMO Capital
10/15/21 Cantor Fitzgerald
Incyte price target lowered to $79 from $104 at Cantor Fitzgerald
10/04/21 Truist
Incyte price target lowered to $95 from $120 at Truist
09/28/21 B. Riley
Syndax collaboration 'significant vote of confidence,' says B. Riley
JAGX Jaguar Health
$1.23 /

+0.065 (+5.58%)

07/07/21
Fly Intel: Top five analyst initiations
07/07/21 Cantor Fitzgerald
Jaguar Health initiated with an Overweight at Cantor Fitzgerald
02/24/21 Ladenburg
Jaguar Health transferred with Buy, $3.75 target at Ladenburg
LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
MGNX MacroGenics
$17.22 /

+0.5 (+2.99%)

11/17/21 Guggenheim
MacroGenics assumed with a Buy at Guggenheim
10/19/21 JMP Securities
MacroGenics initiated with an Outperform at JMP Securities
10/14/21 BTIG
MacroGenics assumed with a Buy at BTIG
06/07/21 Wedbush
MacroGenics price target lowered to $34 from $39 at Wedbush
MRK Merck
$72.16 /

-1.26 (-1.72%)

12/07/21
Fly Intel: Top five analyst downgrades
12/07/21 Guggenheim
Guggenheim downgrades Merck on Keytruda concentration, low pipeline visibility
12/07/21 Guggenheim
Merck downgraded to Neutral from Buy at Guggenheim
11/29/21
Fly Intel: Top five analyst downgrades
MYGN Myriad Genetics
$26.16 /

+1.17 (+4.68%)

10/14/21 Cowen
Myriad Genetics coverage transferred at Cowen
06/15/21 Raymond James
Myriad Genetics initiated with a Market Perform at Raymond James
06/03/21 Goldman Sachs
Myriad Genetics initiated with a Sell at Goldman Sachs
NTRA Natera
$92.20 /

+6.06 (+7.04%)

11/05/21 Baird
Natera price target raised to $152 from $145 at Baird
10/19/21 Canaccord
Natera Prospera Lung launch to continue momentum, says Canaccord
10/14/21 Cowen
Natera coverage transferred at Cowen
08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
NEO NeoGenomics
$34.37 /

+2.78 (+8.80%)

12/07/21 Needham
NeoGenomics price target lowered to $41 from $48 at Needham
11/05/21 Morgan Stanley
Morgan Stanley downgrades NeoGenomics, sees limited near-term upside
11/05/21 Morgan Stanley
NeoGenomics downgraded to Equal Weight from Overweight at Morgan Stanley
10/14/21 Raymond James
NeoGenomics upgraded to Outperform from Market Perform at Raymond James
NVS Novartis
$80.49 /

-0.03 (-0.04%)

12/06/21 Exane BNP Paribas
Novartis downgraded to Neutral from Outperform at Exane BNP Paribas
12/03/21
Fly Intel: Top five analyst downgrades
12/03/21 Bryan Garnier
Novartis downgraded to Neutral on pipeline concerns at Bryan Garnier
12/03/21 Bryan Garnier
Novartis downgraded to Neutral from Buy at Bryan Garnier
OLMA Olema Oncology
$11.28 /

+0.78 (+7.43%)

12/06/21 Cowen
Olema Oncology assumed with an Outperform at Cowen
12/06/21 Cowen
Olema Oncology assumed with an Outperform at Cowen
10/11/21
Olema Oncology participates in a conference call with JPMorgan
05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
OCX OncoCyte
$2.42 /

+0.11 (+4.76%)

04/12/21 Lake Street
AACR data strengthens 'pan-cancer credentials' for OncoCyte, says Lake Street
04/12/21 Piper Sandler
OncoCyte remains a top pick small-cap pick at Piper Sandler
03/30/21 Piper Sandler
OncoCyte called 'top small-cap pick' at Piper Sandler
03/17/21
Fly Intel: Top five analyst initiations
ONCY Oncolytics
$1.68 /

+0.07 (+4.35%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
PBYI Puma Biotechnology
$3.00 /

+0.03 (+1.01%)

09/28/21
Fly Intel: Top five analyst upgrades
09/28/21 Citi
Puma Biotechnology upgraded to Buy after 40% selloff at Citi
09/27/21 Citi
Puma Biotechnology upgraded to Buy from Neutral at Citi
12/24/20 Craig-Hallum
Celcuity price target raised to $19 from $16 at Craig-Hallum
PFE Pfizer
$51.75 /

+0.25 (+0.49%)

12/06/21 BofA
BioNTech price target raised to $349 from $341 at BofA
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
RHHBY Roche
$49.73 /

+0.38 (+0.77%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
SNY Sanofi
$47.51 /

-0.06 (-0.13%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SGEN Seagen
$148.08 /

+2.06 (+1.41%)

11/08/21 Wolfe Research
Seagen initiated with a Peer Perform at Wolfe Research
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
10/28/21 Piper Sandler
Seagen price target raised to $165 from $160 at Piper Sandler
SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
VCYT Veracyte
$40.67 /

+3.12 (+8.31%)

11/18/21 Goldman Sachs
Veracyte reinstated with a Buy at Goldman Sachs
11/10/21 Raymond James
Veracyte price target raised to $62 from $50 at Raymond James
06/28/21 Raymond James
Veracyte price target raised to $50 from $45 at Raymond James
06/15/21 Raymond James
Veracyte initiated with an Outperform at Raymond James
VERU Veru
$6.32 /

+0.14 (+2.27%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VTRS Viatris
$12.50 /

+0.065 (+0.52%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
ZYME Zymeworks
$18.97 /

+0.735 (+4.03%)

11/17/21 Guggenheim
Zymeworks assumed with a Neutral at Guggenheim
10/06/21 Jefferies
Zymeworks initiated with a Hold at Jefferies
09/13/21 Raymond James
Zymeworks data continue to outperform Herceptin, says Raymond James
08/05/21 H.C. Wainwright
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright
ZYME Zymeworks
$18.97 /

+0.735 (+4.03%)

VTRS Viatris
$12.50 /

+0.065 (+0.52%)

VERU Veru
$6.32 /

+0.14 (+2.27%)

VCYT Veracyte
$40.67 /

+3.12 (+8.31%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.51 /

-0.06 (-0.13%)

SGEN Seagen
$148.08 /

+2.06 (+1.41%)

RHHBY Roche
$49.73 /

+0.38 (+0.77%)

PFE Pfizer
$51.75 /

+0.25 (+0.49%)

PBYI Puma Biotechnology
$3.00 /

+0.03 (+1.01%)

ONCY Oncolytics
$1.68 /

+0.07 (+4.35%)

OCX OncoCyte
$2.42 /

+0.11 (+4.76%)

NVS Novartis
$80.49 /

-0.03 (-0.04%)

NTRA Natera
$92.20 /

+6.06 (+7.04%)

MYGN Myriad Genetics
$26.16 /

+1.17 (+4.68%)

MRK Merck
$72.16 /

-1.26 (-1.72%)

MGNX MacroGenics
$17.22 /

+0.5 (+2.99%)

LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

INCY Incyte
$66.58 /

+1.57 (+2.42%)

GILD Gilead
$69.06 /

-0.44 (-0.63%)

GH Guardant Health
$94.94 /

+6.3 (+7.11%)

EXAS Exact Sciences
$83.65 /

+2.75 (+3.40%)

BYSI BeyondSpring
$4.59 /

+0.5 (+12.22%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

  • 22
    Jul
  • 20
    Oct
  • 18
    Feb
  • 05
    Feb
  • 05
    Feb
  • 07
    Jan
ZYME Zymeworks
$18.97 /

+0.735 (+4.03%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.51 /

-0.06 (-0.13%)

RHHBY Roche
$49.73 /

+0.38 (+0.77%)

PFE Pfizer
$51.75 /

+0.25 (+0.49%)

NVS Novartis
$80.49 /

-0.03 (-0.04%)

NEO NeoGenomics
$34.37 /

+2.78 (+8.80%)

MRK Merck
$72.16 /

-1.26 (-1.72%)

LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

GILD Gilead
$69.06 /

-0.44 (-0.63%)

GH Guardant Health
$94.94 /

+6.3 (+7.11%)

EXAS Exact Sciences
$83.65 /

+2.75 (+3.40%)

ESALY Eisai
$60.67 /

+0.47 (+0.78%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

ZYME Zymeworks
$18.97 /

+0.735 (+4.03%)

VCYT Veracyte
$40.67 /

+3.12 (+8.31%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

SNY Sanofi
$47.51 /

-0.06 (-0.13%)

SGEN Seagen
$148.08 /

+2.06 (+1.41%)

RHHBY Roche
$49.73 /

+0.38 (+0.77%)

PFE Pfizer
$51.75 /

+0.25 (+0.49%)

PBYI Puma Biotechnology
$3.00 /

+0.03 (+1.01%)

OLMA Olema Oncology
$11.28 /

+0.78 (+7.43%)

NVS Novartis
$80.49 /

-0.03 (-0.04%)

NTRA Natera
$92.20 /

+6.06 (+7.04%)

NEO NeoGenomics
$34.37 /

+2.78 (+8.80%)

MGNX MacroGenics
$17.22 /

+0.5 (+2.99%)

LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

JAGX Jaguar Health
$1.23 /

+0.065 (+5.58%)

INCY Incyte
$66.58 /

+1.57 (+2.42%)

GILD Gilead
$69.06 /

-0.44 (-0.63%)

GH Guardant Health
$94.94 /

+6.3 (+7.11%)

EXAS Exact Sciences
$83.65 /

+2.75 (+3.40%)

ESALY Eisai
$60.67 /

+0.47 (+0.78%)

CNTX Context Therapeutics
$5.63 /

+0.04 (+0.72%)

BYSI BeyondSpring
$4.59 /

+0.5 (+12.22%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

VTRS Viatris
$12.50 /

+0.065 (+0.52%)

SPPI Spectrum
$1.54 /

+0.17 (+12.41%)

PFE Pfizer
$51.75 /

+0.25 (+0.49%)

NVS Novartis
$80.49 /

-0.03 (-0.04%)

MRK Merck
$72.16 /

-1.26 (-1.72%)

LLY Eli Lilly
$243.25 /

-2.945 (-1.20%)

INCY Incyte
$66.58 /

+1.57 (+2.42%)

GILD Gilead
$69.06 /

-0.44 (-0.63%)

BYSI BeyondSpring
$4.59 /

+0.5 (+12.22%)

AZN AstraZeneca
$53.65 /

-1.76 (-3.18%)

Hot Stocks
Predictive appoints Brush as SVP of Strategic Sales, Business Development » 08:43
12/07/21
12/07
08:43
12/07/21
08:43
POAI

Predictive Oncology

/

+

, LLY

Eli Lilly

$246.31 /

+0.785 (+0.32%)

Predictive Oncology…

Predictive Oncology (POAI) announced that Pamela Bush, Ph.D., MBA would be joining the company's leadership team as SVP of Strategic Sales and Business Development. In addition to her sales role, Bush will work with the company's senior leadership team to identify opportunities for business development, including additional acquisitions and licensing agreements. Before coming to Predictive Oncology, Bush served as the Director of Immunology at Lilly Patient Services, Eli Lilly & Company (LLY)

ShowHide Related Items >><<
POAI Predictive Oncology
/

+

LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

POAI Predictive Oncology
/

+

06/30/21 H.C. Wainwright
Predictive Oncology initiated with a Buy at H.C. Wainwright
02/01/21 Litchfield Hills
Predictive Oncology initiated with a Buy at Litchfield Hills
LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
POAI Predictive Oncology
/

+

LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

LLY Eli Lilly
$246.31 /

+0.785 (+0.32%)

Friday
On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:20
12/03/21
12/03
16:20
12/03/21
16:20
DIDI

Didi

$6.07 /

-1.73 (-22.18%)

, DOCU

DocuSign

$135.03 /

-99.22 (-42.36%)

, MRNA

Moderna

$306.66 /

+5.2 (+1.72%)

, PFE

Pfizer

$54.27 /

+1.25 (+2.36%)

, JNJ

Johnson & Johnson

$159.37 /

+2.25 (+1.43%)

, BNTX

BioNTech

$343.83 /

+11.05 (+3.32%)

, AZN

AstraZeneca

$54.25 /

-0.535 (-0.98%)

, MRK

Merck

$73.32 /

-0.57 (-0.77%)

, LLY

Eli Lilly

$245.56 /

-2.36 (-0.95%)

, REGN

Regeneron

$635.78 /

+2.69 (+0.42%)

, APSG

Apollo Strategic Growth Capital

$9.92 /

+0.09 (+0.92%)

, AXP

American Express

$155.91 /

-0.9 (-0.57%)

, MRVL

Marvell

$83.76 /

+12.74 (+17.94%)

, PTON

Peloton

$43.60 /

-0.855 (-1.92%)

, FSLY

Fastly

$35.92 /

-0.53 (-1.45%)

, UPST

Upstart

$171.47 /

-5.24 (-2.97%)

, AAPL

Apple

$161.85 /

-1.95 (-1.19%)

, C

Citi

$62.70 /

-1.1 (-1.72%)

, TSLA

Tesla

$1,014.65 /

-69.85 (-6.44%)

, WBA

Walgreens Boots Alliance

$46.56 /

+1.92 (+4.30%)

, Z

Zillow

$60.41 /

+6.14 (+11.31%)

, ZG

Zillow Group

$59.46 /

+5.74 (+10.69%)

, NUE

Nucor

$110.49 /

+3.23 (+3.01%)

, SPWR

SunPower

$24.42 /

-2.495 (-9.27%)

, ESPR

Esperion

$5.23 /

-3.76 (-41.82%)

, SPWH

Sportsman's Warehouse

$13.62 /

-3.3 (-19.50%)

, APPN

Appian

$69.42 /

+0.48 (+0.70%)

, HIBB

Hibbett Sports

$69.08 /

-3.13 (-4.33%)

, BIG

Big Lots

$46.01 /

+2.39 (+5.48%)

, ULTA

Ulta Beauty

$379.07 /

-4.17 (-1.09%)

, ASAN

Asana

$67.01 /

-24.155 (-26.50%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$59.46 /

+5.74 (+10.69%)

Z Zillow
$60.41 /

+6.14 (+11.31%)

WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

UPST Upstart
$171.47 /

-5.24 (-2.97%)

ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

SPWR SunPower
$24.42 /

-2.495 (-9.27%)

SPWH Sportsman's Warehouse
$13.62 /

-3.3 (-19.50%)

REGN Regeneron
$635.78 /

+2.69 (+0.42%)

PTON Peloton
$43.60 /

-0.855 (-1.92%)

PFE Pfizer
$54.27 /

+1.25 (+2.36%)

NUE Nucor
$110.49 /

+3.23 (+3.01%)

MRVL Marvell
$83.76 /

+12.74 (+17.94%)

MRNA Moderna
$306.66 /

+5.2 (+1.72%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

HIBB Hibbett Sports
$69.08 /

-3.13 (-4.33%)

FSLY Fastly
$35.92 /

-0.53 (-1.45%)

ESPR Esperion
$5.23 /

-3.76 (-41.82%)

DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

DIDI Didi
$6.07 /

-1.73 (-22.18%)

C Citi
$62.70 /

-1.1 (-1.72%)

BNTX BioNTech
$343.83 /

+11.05 (+3.32%)

BIG Big Lots
$46.01 /

+2.39 (+5.48%)

AZN AstraZeneca
$54.25 /

-0.535 (-0.98%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

APPN Appian
$69.42 /

+0.48 (+0.70%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

DIDI Didi
$6.07 /

-1.73 (-22.18%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

12/03/21
Fly Intel: Top five analyst downgrades
12/03/21 Oppenheimer
DocuSign now 'show me stock' after 'soft' Q3, says Oppenheimer
12/03/21 RBC Capital
DocuSign price target lowered to $220 from $345 at RBC Capital
12/03/21 Wedbush
DocuSign downgraded to Neutral at Wedbush after 'debacle quarter'
MRNA Moderna
$306.66 /

+5.2 (+1.72%)

12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
PFE Pfizer
$54.27 /

+1.25 (+2.36%)

11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
BNTX BioNTech
$343.83 /

+11.05 (+3.32%)

11/29/21 UBS
BioNTech to benefit if concerns about omicron variant increase, says UBS
11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
AZN AstraZeneca
$54.25 /

-0.535 (-0.98%)

12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
MRK Merck
$73.32 /

-0.57 (-0.77%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
REGN Regeneron
$635.78 /

+2.69 (+0.42%)

12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

10/29/21 Citi
Citi upgrades Synchrony to Buy on higher loan growth estiamtes
10/25/21 BMO Capital
American Express price target raised to $151 from $147 at BMO Capital
10/25/21 Deutsche Bank
American Express price target raised to $200 from $190 at Deutsche Bank
10/25/21 Stephens
American Express price target raised to $190 from $180 at Stephens
MRVL Marvell
$83.76 /

+12.74 (+17.94%)

12/03/21
Fly Intel: Top five analyst upgrades
12/03/21 Craig-Hallum
Marvell price target raised to $108 from $85 at Craig-Hallum
12/03/21 B. Riley
Marvell price target raised to $115 from $90 at B. Riley
12/03/21 Stifel
Marvell price target raised to $100 from $80 at Stifel
PTON Peloton
$43.60 /

-0.855 (-1.92%)

12/03/21
Fly Intel: Top five analyst initiations
12/03/21 Deutsche Bank
Peloton initiated with a Buy at Deutsche Bank
11/29/21 Stifel
Peloton price target lowered to $56 from $70 at Stifel
11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
FSLY Fastly
$35.92 /

-0.53 (-1.45%)

12/03/21 Raymond James
Raymond James upgrades Fastly on selloff, uptick in traffic
12/03/21 Raymond James
Fastly upgraded to Outperform from Market Perform at Raymond James
09/08/21 Evercore ISI
Evercore says Akamai, Cloudflare, Fastly may partner with Apple on new service
UPST Upstart
$171.47 /

-5.24 (-2.97%)

12/03/21 Citi
Citi upgrades Upstart to Buy on resumption after 55% selloff
12/03/21 Citi
Upstart upgraded to Buy from Neutral at Citi
11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
AAPL Apple
$161.85 /

-1.95 (-1.19%)

12/03/21 JPMorgan
JPMorgan does not think Apple cut Q4 iPhone orders despite report
12/02/21 Wedbush
Wedbush sees $3 trillion market cap for Apple in 2022, ups price target
12/01/21 UBS
Apple wait times showing 'modest' easing, says UBS
11/26/21 Wedbush
Wedbush sees Apple on pace to sell over 10M iPhones over Black Friday weekend
C Citi
$62.70 /

-1.1 (-1.72%)

10/15/21 BMO Capital
Citi price target raised to $86 from $84 at BMO Capital
10/11/21 Jefferies
Citi price target raised to $87 from $81 at Jefferies
09/29/21 Oppenheimer
Morgan Stanley downgraded to Perform at Oppenheimer on valuation
07/15/21 Piper Sandler
Citi price target lowered to $91 from $95 at Piper Sandler
TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

11/30/21 GLJ Research
Tesla 'leak' an attempt to lower, then beat, Q4 expectations, says GLJ Research
11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

10/15/21 Truist
Walgreens Boots Alliance price target raised to $56 from $52 at Truist
07/06/21 Barclays
Walgreens Boots Alliance price target lowered to $53 from $55 at Barclays
07/02/21 Truist
Walgreens Boots Alliance price target lowered to $52 from $58 at Truist
07/02/21 Deutsche Bank
Walgreens Boots Alliance price target lowered to $52 from $55 at Deutsche Bank
Z Zillow
$60.41 /

+6.14 (+11.31%)

12/03/21 Jefferies
Zillow trading at 'steep discount' to pre-iBuying days, says Jefferies
11/22/21 Piper Sandler
October housing data positive for Redfin and Zillow, says Piper Sandler
11/19/21 Piper Sandler
Zillow Group price target lowered to $68 from $78 at Piper Sandler
11/04/21 Citi
Citi downgrades Zillow with shares in 'penalty box' on homes exit
ZG Zillow Group
$59.46 /

+5.74 (+10.69%)

12/03/21 Craig-Hallum
Zillow Group price target lowered to $76 from $95 at Craig-Hallum
NUE Nucor
$110.49 /

+3.23 (+3.01%)

11/16/21 Wolfe Research
Nucor initiated with a Peer Perform at Wolfe Research
11/09/21 Citi
Nucor downgraded to Neutral from Buy at Citi
10/18/21 Morgan Stanley
Nucor price target lowered to $105 from $115 at Morgan Stanley
10/06/21
Fly Intel: Top five analyst downgrades
SPWR SunPower
$24.42 /

-2.495 (-9.27%)

12/03/21 BofA
Maxeon Solar upgraded to Buy on core turnaround at BofA
12/02/21 JPMorgan
Concerns over California net metering program overblown, says JPMorgan
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
11/11/21 Morgan Stanley
Commerce rejection negative for First Solar, Maxeon, says Morgan Stanley
ESPR Esperion
$5.23 /

-3.76 (-41.82%)

10/19/21 Cowen
Esperion price target lowered to $30 from $60 at Cowen
10/18/21 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
10/14/21 Morgan Stanley
Morgan Stanley cuts Esperion to Underweight, lacks confidence in near-term
10/14/21 Morgan Stanley
Esperion downgraded to Underweight from Equal Weight at Morgan Stanley
SPWH Sportsman's Warehouse
$13.62 /

-3.3 (-19.50%)

12/03/21 Craig-Hallum
Sportsman's Warehouse upgraded to Buy from Hold at Craig-Hallum
01/07/21 Credit Suisse
Sportsman's Warehouse downgraded to Neutral from Outperform at Credit Suisse
12/22/20 Lake Street
Sportsman's Warehouse downgraded to Hold from Buy at Lake Street
12/22/20 Craig-Hallum
Sportsman's Warehouse downgraded to Hold from Buy at Craig-Hallum
APPN Appian
$69.42 /

+0.48 (+0.70%)

12/03/21 Morgan Stanley
Appian upgraded to Equal Weight at Morgan Stanley on more reasonable valuation
12/03/21 Morgan Stanley
Appian upgraded to Equal Weight from Underweight at Morgan Stanley
11/08/21
Fly Intel: Top five analyst upgrades
11/08/21 Truist
Appian upgraded to Buy from Hold at Truist
HIBB Hibbett Sports
$69.08 /

-3.13 (-4.33%)

12/02/21
Fly Intel: Top five analyst downgrades
12/02/21 BofA
BofA downgrades Hibbett on less stimulus, inventory challenges
12/02/21 BofA
Hibbett Sports downgraded to Neutral from Buy at BofA
08/30/21 BofA
Hibbett Sports price target raised to $120 from $110 at BofA
BIG Big Lots
$46.01 /

+2.39 (+5.48%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

12/03/21 Evercore ISI
Ulta Beauty price target raised to $500 from $475 at Evercore ISI
12/03/21 Jefferies
Ulta Beauty price target raised to $400 from $390 at Jefferies
12/03/21 BMO Capital
Ulta Beauty price target raised to $365 from $345 at BMO Capital
12/03/21 Credit Suisse
Ulta Beauty price target raised to $455 from $415 at Credit Suisse
ASAN Asana
$67.01 /

-24.155 (-26.50%)

12/03/21 JMP Securities
Asana price target raised to $95 from $85 at JMP Securities
11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
ZG Zillow Group
$59.46 /

+5.74 (+10.69%)

Z Zillow
$60.41 /

+6.14 (+11.31%)

WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

UPST Upstart
$171.47 /

-5.24 (-2.97%)

ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

SPWR SunPower
$24.42 /

-2.495 (-9.27%)

REGN Regeneron
$635.78 /

+2.69 (+0.42%)

PTON Peloton
$43.60 /

-0.855 (-1.92%)

PFE Pfizer
$54.27 /

+1.25 (+2.36%)

NUE Nucor
$110.49 /

+3.23 (+3.01%)

MRVL Marvell
$83.76 /

+12.74 (+17.94%)

MRNA Moderna
$306.66 /

+5.2 (+1.72%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

HIBB Hibbett Sports
$69.08 /

-3.13 (-4.33%)

FSLY Fastly
$35.92 /

-0.53 (-1.45%)

ESPR Esperion
$5.23 /

-3.76 (-41.82%)

DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

C Citi
$62.70 /

-1.1 (-1.72%)

BNTX BioNTech
$343.83 /

+11.05 (+3.32%)

BIG Big Lots
$46.01 /

+2.39 (+5.48%)

AZN AstraZeneca
$54.25 /

-0.535 (-0.98%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

APPN Appian
$69.42 /

+0.48 (+0.70%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

  • 03
    Dec
  • 16
    Nov
  • 30
    Jun
  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
Z Zillow
$60.41 /

+6.14 (+11.31%)

WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

SPWR SunPower
$24.42 /

-2.495 (-9.27%)

PTON Peloton
$43.60 /

-0.855 (-1.92%)

PFE Pfizer
$54.27 /

+1.25 (+2.36%)

NUE Nucor
$110.49 /

+3.23 (+3.01%)

MRVL Marvell
$83.76 /

+12.74 (+17.94%)

MRNA Moderna
$306.66 /

+5.2 (+1.72%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

FSLY Fastly
$35.92 /

-0.53 (-1.45%)

DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

DIDI Didi
$6.07 /

-1.73 (-22.18%)

C Citi
$62.70 /

-1.1 (-1.72%)

AZN AstraZeneca
$54.25 /

-0.535 (-0.98%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

Z Zillow
$60.41 /

+6.14 (+11.31%)

WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

UPST Upstart
$171.47 /

-5.24 (-2.97%)

ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

SPWR SunPower
$24.42 /

-2.495 (-9.27%)

REGN Regeneron
$635.78 /

+2.69 (+0.42%)

PFE Pfizer
$54.27 /

+1.25 (+2.36%)

NUE Nucor
$110.49 /

+3.23 (+3.01%)

MRVL Marvell
$83.76 /

+12.74 (+17.94%)

MRNA Moderna
$306.66 /

+5.2 (+1.72%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

HIBB Hibbett Sports
$69.08 /

-3.13 (-4.33%)

FSLY Fastly
$35.92 /

-0.53 (-1.45%)

DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

DIDI Didi
$6.07 /

-1.73 (-22.18%)

C Citi
$62.70 /

-1.1 (-1.72%)

BNTX BioNTech
$343.83 /

+11.05 (+3.32%)

BIG Big Lots
$46.01 /

+2.39 (+5.48%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

ZG Zillow Group
$59.46 /

+5.74 (+10.69%)

Z Zillow
$60.41 /

+6.14 (+11.31%)

WBA Walgreens Boots Alliance
$46.56 /

+1.92 (+4.30%)

UPST Upstart
$171.47 /

-5.24 (-2.97%)

ULTA Ulta Beauty
$379.07 /

-4.17 (-1.09%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

SPWR SunPower
$24.42 /

-2.495 (-9.27%)

REGN Regeneron
$635.78 /

+2.69 (+0.42%)

PTON Peloton
$43.60 /

-0.855 (-1.92%)

PFE Pfizer
$54.27 /

+1.25 (+2.36%)

NUE Nucor
$110.49 /

+3.23 (+3.01%)

MRVL Marvell
$83.76 /

+12.74 (+17.94%)

MRNA Moderna
$306.66 /

+5.2 (+1.72%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

LLY Eli Lilly
$245.56 /

-2.36 (-0.95%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

FSLY Fastly
$35.92 /

-0.53 (-1.45%)

DOCU DocuSign
$135.03 /

-99.22 (-42.36%)

DIDI Didi
$6.07 /

-1.73 (-22.18%)

C Citi
$62.70 /

-1.1 (-1.72%)

BNTX BioNTech
$343.83 /

+11.05 (+3.32%)

AZN AstraZeneca
$54.25 /

-0.535 (-0.98%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

ASAN Asana
$67.01 /

-24.155 (-26.50%)

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

Hot Stocks
AbCellera says FDA expands EUA for bamlanivimab-etesevimab combo » 16:06
12/03/21
12/03
16:06
12/03/21
16:06
LLY

Eli Lilly

$244.52 /

-3.4 (-1.37%)

, ABCL

AbCellera

$13.99 /

-0.84 (-5.66%)

AbCellera (ABCL)…

AbCellera (ABCL) announced the U.S. Food and Drug Administration has expanded the Emergency Use Authorization for bamlanivimab and etesevimab administered together to include pediatric patients under the age of 12, including neonates. The EUA allows for bamlanivimab and etesevimab administered together in the treatment of mild to moderate COVID-19 as well as post-exposure prophylaxis in certain patients. The expanded EUA is based on data from the BLAZE-1 Phase 2/3 clinical trial studying bamlanivimab and etesevimab administered together for the treatment of pediatric and infant patients with mild to moderate COVID-19 and who are at high risk for severe disease progression. The median time to complete symptom resolution as recorded in a trial specific daily symptom diary was 7 days for subjects treated with bamlanivimab 700 mg and etesevimab 1,400 mg and 5 days for subjects treated with weight-based dosing of bamlanivimab and etesevimab. No subject died or required hospitalization due to COVID-19. Pseudovirus and authentic virus studies conducted by AbCellera's partner, Eli Lilly and Company (LLY), demonstrate that bamlanivimab and etesevimab together retain neutralization activity against the Delta variant, which is currently the predominant variant of concern within the U.S.

ShowHide Related Items >><<
LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

ABCL AbCellera
$13.99 /

-0.84 (-5.66%)

LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
ABCL AbCellera
$13.99 /

-0.84 (-5.66%)

11/18/21 Piper Sandler
AbCellera initiated with an Overweight at Piper Sandler
11/05/21 Stifel
Stifel sees 'zero change' to Adagio, AbCellera theses due to Pfizer data
10/01/21 Stifel
AbCellera, Adagio reactions to Merck data look 'overdone,' says Stifel
06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

ABCL AbCellera
$13.99 /

-0.84 (-5.66%)

  • 11
    Dec
LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

ABCL AbCellera
$13.99 /

-0.84 (-5.66%)

LLY Eli Lilly
$244.52 /

-3.4 (-1.37%)

ABCL AbCellera
$13.99 /

-0.84 (-5.66%)

Hot Stocks
Eli Lilly confirms FDA expanded EUA for bamlanivimab and etesevimab combo » 14:54
12/03/21
12/03
14:54
12/03/21
14:54
LLY

Eli Lilly

$243.80 /

-4.12 (-1.66%)

The U.S. Food and Drug…

The U.S. Food and Drug Administration has expanded the Emergency Use Authorization, or EUA, for bamlanivimab and etesevimab administered together to include certain high-risk pediatric patients from birth to less than 12 years old, Eli Lilly and Company announced. This expansion allows for bamlanivimab and etesevimab to be administered together in high-risk pediatric patients for the treatment of mild to moderate COVID-19 as well as post-exposure prophylaxis, the company noted. "Our mission since the start of the pandemic has been to offer crucial support by developing therapeutic options that could prevent hospitalization and death for as many people as possible. With the FDA's decision to allow use of bamlanivimab with etesevimab in children and infants, Lilly can now offer treatment and prevention options to high-risk individuals of any age," said Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific and medical officer, and president of Lilly Research Laboratories.

ShowHide Related Items >><<
LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

LLY Eli Lilly
$243.80 /

-4.12 (-1.66%)

Hot Stocks
FDA expands authorization of Eli Lilly COVID-19 antibodies to younger patients » 14:30
12/03/21
12/03
14:30
12/03/21
14:30
LLY

Eli Lilly

$243.95 /

-3.97 (-1.60%)

The U.S. Food and Drug…

The U.S. Food and Drug Administration revised the emergency use authorization of bamlanivimab and etesevimab, previously authorized for pediatric patients 12 years of age and older weighing at least 40 kilograms, or about 88 pounds, to additionally authorize bamlanivimab and etesivimab administered together for the treatment of mild to moderate COVID-19 in all younger pediatric patients, including newborns, who have a positive COVID-19 test and are at high risk for progression to severe COVID-19, including hospitalization or death. This revision also authorizes bamlanivimab and etesevimab, to be administered together, for post-exposure prophylaxis for prevention of COVID-19 in all pediatric patients, including newborns, at high risk of progression to severe COVID-19, including hospitalization or death. The EUA was issued to Eli Lilly and Co. Reference Link

ShowHide Related Items >><<
LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

LLY Eli Lilly
$243.95 /

-3.97 (-1.60%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:04
12/03/21
12/03
12:04
12/03/21
12:04
DOCU

DocuSign

$140.82 /

-93.43 (-39.88%)

, DIDI

Didi

$6.44 /

-1.36 (-17.44%)

, PTON

Peloton

$42.57 /

-1.885 (-4.24%)

, MRVL

Marvell

$83.53 /

+12.51 (+17.61%)

, ULTA

Ulta Beauty

$376.50 /

-6.74 (-1.76%)

, ASAN

Asana

$68.34 /

-22.82 (-25.03%)

, MRNA

Moderna

$297.98 /

-3.48 (-1.15%)

, PFE

Pfizer

$53.56 /

+0.54 (+1.02%)

, BNTX

BioNTech

$335.35 /

+2.57 (+0.77%)

, JNJ

Johnson & Johnson

$159.22 /

+2.105 (+1.34%)

, AZN

AstraZeneca

$54.16 /

-0.62 (-1.13%)

, MRK

Merck

$73.51 /

-0.38 (-0.51%)

, LLY

Eli Lilly

$246.09 /

-1.83 (-0.74%)

, REGN

Regeneron

$627.00 /

-6.09 (-0.96%)

, AAPL

Apple

$161.15 /

-2.65 (-1.62%)

, UI

Ubiquiti

$298.54 /

-6.44 (-2.11%)

, CS

Credit Suisse

$9.58 /

-0.14 (-1.44%)

, TSLA

Tesla

$1,014.85 /

-69.65 (-6.42%)

, C

Citi

$63.41 /

-0.39 (-0.61%)

, Z

Zillow

$57.99 /

+3.72 (+6.85%)

, ZG

Zillow Group

$57.37 /

+3.65 (+6.79%)

, NUE

Nucor

$111.75 /

+4.49 (+4.19%)

, SPWR

SunPower

$25.02 /

-1.89 (-7.02%)

, ESPR

Esperion

$5.40 /

-3.59 (-39.93%)

, SPWH

Sportsman's Warehouse

$13.99 /

-2.935 (-17.35%)

, APPN

Appian

$66.21 /

-2.73 (-3.96%)

, HIBB

Hibbett Sports

$66.16 /

-6.05 (-8.38%)

, BIG

Big Lots

$46.79 /

+3.17 (+7.27%)

, COO

Cooper Companies

$391.03 /

+12.94 (+3.42%)

, YEXT

Yext

$10.09 /

+0.67 (+7.11%)

, FSLY

Fastly

$35.95 /

-0.5 (-1.37%)

, UPST

Upstart

$171.90 /

-4.81 (-2.72%)

Get caught up quickly on…

ShowHide Related Items >><<
ZG Zillow Group
$57.37 /

+3.65 (+6.79%)

Z Zillow
$57.99 /

+3.72 (+6.85%)

YEXT Yext
$10.09 /

+0.67 (+7.11%)

UPST Upstart
$171.90 /

-4.81 (-2.72%)

ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

UI Ubiquiti
$298.54 /

-6.44 (-2.11%)

TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

SPWR SunPower
$25.02 /

-1.89 (-7.02%)

SPWH Sportsman's Warehouse
$13.99 /

-2.935 (-17.35%)

REGN Regeneron
$627.00 /

-6.09 (-0.96%)

PTON Peloton
$42.57 /

-1.885 (-4.24%)

PFE Pfizer
$53.56 /

+0.54 (+1.02%)

NUE Nucor
$111.75 /

+4.49 (+4.19%)

MRVL Marvell
$83.53 /

+12.51 (+17.61%)

MRNA Moderna
$297.98 /

-3.48 (-1.15%)

MRK Merck
$73.51 /

-0.38 (-0.51%)

LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

HIBB Hibbett Sports
$66.16 /

-6.05 (-8.38%)

FSLY Fastly
$35.95 /

-0.5 (-1.37%)

ESPR Esperion
$5.40 /

-3.59 (-39.93%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

DIDI Didi
$6.44 /

-1.36 (-17.44%)

CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

COO Cooper Companies
$391.03 /

+12.94 (+3.42%)

C Citi
$63.41 /

-0.39 (-0.61%)

BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

BIG Big Lots
$46.79 /

+3.17 (+7.27%)

AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

ASAN Asana
$68.34 /

-22.82 (-25.03%)

APPN Appian
$66.21 /

-2.73 (-3.96%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

12/03/21
Fly Intel: Top five analyst downgrades
12/03/21 Oppenheimer
DocuSign now 'show me stock' after 'soft' Q3, says Oppenheimer
12/03/21 RBC Capital
DocuSign price target lowered to $220 from $345 at RBC Capital
12/03/21 Wedbush
DocuSign downgraded to Neutral at Wedbush after 'debacle quarter'
DIDI Didi
$6.44 /

-1.36 (-17.44%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
PTON Peloton
$42.57 /

-1.885 (-4.24%)

12/03/21
Fly Intel: Top five analyst initiations
12/03/21 Deutsche Bank
Peloton initiated with a Buy at Deutsche Bank
11/29/21 Stifel
Peloton price target lowered to $56 from $70 at Stifel
11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
MRVL Marvell
$83.53 /

+12.51 (+17.61%)

12/03/21
Fly Intel: Top five analyst upgrades
12/03/21 Craig-Hallum
Marvell price target raised to $108 from $85 at Craig-Hallum
12/03/21 B. Riley
Marvell price target raised to $115 from $90 at B. Riley
12/03/21 Stifel
Marvell price target raised to $100 from $80 at Stifel
ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

12/03/21 Evercore ISI
Ulta Beauty price target raised to $500 from $475 at Evercore ISI
12/03/21 Jefferies
Ulta Beauty price target raised to $400 from $390 at Jefferies
12/03/21 BMO Capital
Ulta Beauty price target raised to $365 from $345 at BMO Capital
12/03/21 Credit Suisse
Ulta Beauty price target raised to $455 from $415 at Credit Suisse
ASAN Asana
$68.34 /

-22.82 (-25.03%)

12/03/21 JMP Securities
Asana price target raised to $95 from $85 at JMP Securities
11/18/21 Piper Sandler
Asana price target raised to $140 from $85 at Piper Sandler
11/04/21 Jefferies
Asana downgraded to Hold from Buy at Jefferies
10/21/21 KeyBanc
Asana price target raised to $143 from $85 at KeyBanc
MRNA Moderna
$297.98 /

-3.48 (-1.15%)

12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
PFE Pfizer
$53.56 /

+0.54 (+1.02%)

11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

11/29/21 UBS
BioNTech to benefit if concerns about omicron variant increase, says UBS
11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
MRK Merck
$73.51 /

-0.38 (-0.51%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
REGN Regeneron
$627.00 /

-6.09 (-0.96%)

12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
AAPL Apple
$161.15 /

-2.65 (-1.62%)

12/02/21 Wedbush
Wedbush sees $3 trillion market cap for Apple in 2022, ups price target
12/01/21 UBS
Apple wait times showing 'modest' easing, says UBS
11/26/21 Wedbush
Wedbush sees Apple on pace to sell over 10M iPhones over Black Friday weekend
11/26/21
Apple to launch AR headset in 2022, TFI Asset's Kuo predicts
UI Ubiquiti
$298.54 /

-6.44 (-2.11%)

04/01/21 Credit Suisse
Ubiquiti price target lowered to $126 from $157 at Credit Suisse
02/08/21 BWS Financial
Ubiquiti price target raised to $370 from $290 at BWS Financial
01/26/21 Jefferies
Cambium Networks initiated with a Buy at Jefferies
01/14/21 Barclays
Barclays stays Underweight on Ubiquiti, questions stability of momentum
CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

11/16/21 JPMorgan
Credit Suisse downgraded to Underweight on new strategy at JPMorgan
11/16/21 JPMorgan
Credit Suisse downgraded to Underweight from Neutral at JPMorgan
11/15/21 Morgan Stanley
Credit Suisse price target raised to CHF 12 from CHF 11 at Morgan Stanley
11/09/21 Keefe Bruyette
Credit Suisse downgraded to Market Perform from Outperform at Keefe Bruyette
TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

11/30/21 GLJ Research
Tesla 'leak' an attempt to lower, then beat, Q4 expectations, says GLJ Research
11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
C Citi
$63.41 /

-0.39 (-0.61%)

10/15/21 BMO Capital
Citi price target raised to $86 from $84 at BMO Capital
10/11/21 Jefferies
Citi price target raised to $87 from $81 at Jefferies
09/29/21 Oppenheimer
Morgan Stanley downgraded to Perform at Oppenheimer on valuation
07/15/21 Piper Sandler
Citi price target lowered to $91 from $95 at Piper Sandler
Z Zillow
$57.99 /

+3.72 (+6.85%)

12/03/21 Jefferies
Zillow trading at 'steep discount' to pre-iBuying days, says Jefferies
11/22/21 Piper Sandler
October housing data positive for Redfin and Zillow, says Piper Sandler
11/19/21 Piper Sandler
Zillow Group price target lowered to $68 from $78 at Piper Sandler
11/04/21 Citi
Citi downgrades Zillow with shares in 'penalty box' on homes exit
ZG Zillow Group
$57.37 /

+3.65 (+6.79%)

12/03/21 Craig-Hallum
Zillow Group price target lowered to $76 from $95 at Craig-Hallum
NUE Nucor
$111.75 /

+4.49 (+4.19%)

11/16/21 Wolfe Research
Nucor initiated with a Peer Perform at Wolfe Research
11/09/21 Citi
Nucor downgraded to Neutral from Buy at Citi
10/18/21 Morgan Stanley
Nucor price target lowered to $105 from $115 at Morgan Stanley
10/06/21
Fly Intel: Top five analyst downgrades
SPWR SunPower
$25.02 /

-1.89 (-7.02%)

12/03/21 BofA
Maxeon Solar upgraded to Buy on core turnaround at BofA
12/02/21 JPMorgan
Concerns over California net metering program overblown, says JPMorgan
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
11/11/21 Morgan Stanley
Commerce rejection negative for First Solar, Maxeon, says Morgan Stanley
ESPR Esperion
$5.40 /

-3.59 (-39.93%)

10/19/21 Cowen
Esperion price target lowered to $30 from $60 at Cowen
10/18/21 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
10/14/21 Morgan Stanley
Morgan Stanley cuts Esperion to Underweight, lacks confidence in near-term
10/14/21 Morgan Stanley
Esperion downgraded to Underweight from Equal Weight at Morgan Stanley
SPWH Sportsman's Warehouse
$13.99 /

-2.935 (-17.35%)

12/03/21 Craig-Hallum
Sportsman's Warehouse upgraded to Buy from Hold at Craig-Hallum
01/07/21 Credit Suisse
Sportsman's Warehouse downgraded to Neutral from Outperform at Credit Suisse
12/22/20 Lake Street
Sportsman's Warehouse downgraded to Hold from Buy at Lake Street
12/22/20 Craig-Hallum
Sportsman's Warehouse downgraded to Hold from Buy at Craig-Hallum
APPN Appian
$66.21 /

-2.73 (-3.96%)

12/03/21 Morgan Stanley
Appian upgraded to Equal Weight at Morgan Stanley on more reasonable valuation
12/03/21 Morgan Stanley
Appian upgraded to Equal Weight from Underweight at Morgan Stanley
11/08/21
Fly Intel: Top five analyst upgrades
11/08/21 Truist
Appian upgraded to Buy from Hold at Truist
HIBB Hibbett Sports
$66.16 /

-6.05 (-8.38%)

12/02/21
Fly Intel: Top five analyst downgrades
12/02/21 BofA
BofA downgrades Hibbett on less stimulus, inventory challenges
12/02/21 BofA
Hibbett Sports downgraded to Neutral from Buy at BofA
08/30/21 BofA
Hibbett Sports price target raised to $120 from $110 at BofA
BIG Big Lots
$46.79 /

+3.17 (+7.27%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
COO Cooper Companies
$391.03 /

+12.94 (+3.42%)

12/03/21 Citi
Cooper Companies price target lowered to $425 from $453 at Citi
10/21/21 KeyBanc
Cooper Companies price target lowered to $465 from $476 at KeyBanc
09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
YEXT Yext
$10.09 /

+0.67 (+7.11%)

03/04/21
Fly Intel: Top five analyst downgrades
03/04/21 Truist
Yext price target lowered to $17 from $23 at Truist
03/04/21 William Blair
Yext downgraded to Market Perform on growth headwinds at William Blair
03/04/21 William Blair
Yext downgraded to Market Perform from Outperform at William Blair
FSLY Fastly
$35.95 /

-0.5 (-1.37%)

12/03/21 Raymond James
Raymond James upgrades Fastly on selloff, uptick in traffic
12/03/21 Raymond James
Fastly upgraded to Outperform from Market Perform at Raymond James
09/08/21 Evercore ISI
Evercore says Akamai, Cloudflare, Fastly may partner with Apple on new service
UPST Upstart
$171.90 /

-4.81 (-2.72%)

12/03/21 Citi
Citi upgrades Upstart to Buy on resumption after 55% selloff
12/03/21 Citi
Upstart upgraded to Buy from Neutral at Citi
11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
ZG Zillow Group
$57.37 /

+3.65 (+6.79%)

Z Zillow
$57.99 /

+3.72 (+6.85%)

YEXT Yext
$10.09 /

+0.67 (+7.11%)

UPST Upstart
$171.90 /

-4.81 (-2.72%)

ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

UI Ubiquiti
$298.54 /

-6.44 (-2.11%)

TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

SPWR SunPower
$25.02 /

-1.89 (-7.02%)

REGN Regeneron
$627.00 /

-6.09 (-0.96%)

PTON Peloton
$42.57 /

-1.885 (-4.24%)

PFE Pfizer
$53.56 /

+0.54 (+1.02%)

NUE Nucor
$111.75 /

+4.49 (+4.19%)

MRVL Marvell
$83.53 /

+12.51 (+17.61%)

MRNA Moderna
$297.98 /

-3.48 (-1.15%)

MRK Merck
$73.51 /

-0.38 (-0.51%)

LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

HIBB Hibbett Sports
$66.16 /

-6.05 (-8.38%)

FSLY Fastly
$35.95 /

-0.5 (-1.37%)

ESPR Esperion
$5.40 /

-3.59 (-39.93%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

COO Cooper Companies
$391.03 /

+12.94 (+3.42%)

C Citi
$63.41 /

-0.39 (-0.61%)

BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

BIG Big Lots
$46.79 /

+3.17 (+7.27%)

AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

ASAN Asana
$68.34 /

-22.82 (-25.03%)

APPN Appian
$66.21 /

-2.73 (-3.96%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

  • 03
    Dec
  • 16
    Nov
  • 30
    Jun
  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
Z Zillow
$57.99 /

+3.72 (+6.85%)

ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

UI Ubiquiti
$298.54 /

-6.44 (-2.11%)

TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

SPWR SunPower
$25.02 /

-1.89 (-7.02%)

PTON Peloton
$42.57 /

-1.885 (-4.24%)

PFE Pfizer
$53.56 /

+0.54 (+1.02%)

NUE Nucor
$111.75 /

+4.49 (+4.19%)

MRVL Marvell
$83.53 /

+12.51 (+17.61%)

MRNA Moderna
$297.98 /

-3.48 (-1.15%)

MRK Merck
$73.51 /

-0.38 (-0.51%)

LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

FSLY Fastly
$35.95 /

-0.5 (-1.37%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

DIDI Didi
$6.44 /

-1.36 (-17.44%)

CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

C Citi
$63.41 /

-0.39 (-0.61%)

BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

ASAN Asana
$68.34 /

-22.82 (-25.03%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

Z Zillow
$57.99 /

+3.72 (+6.85%)

YEXT Yext
$10.09 /

+0.67 (+7.11%)

UPST Upstart
$171.90 /

-4.81 (-2.72%)

ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

UI Ubiquiti
$298.54 /

-6.44 (-2.11%)

TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

SPWR SunPower
$25.02 /

-1.89 (-7.02%)

REGN Regeneron
$627.00 /

-6.09 (-0.96%)

PTON Peloton
$42.57 /

-1.885 (-4.24%)

PFE Pfizer
$53.56 /

+0.54 (+1.02%)

NUE Nucor
$111.75 /

+4.49 (+4.19%)

MRVL Marvell
$83.53 /

+12.51 (+17.61%)

MRNA Moderna
$297.98 /

-3.48 (-1.15%)

MRK Merck
$73.51 /

-0.38 (-0.51%)

LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

FSLY Fastly
$35.95 /

-0.5 (-1.37%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

DIDI Didi
$6.44 /

-1.36 (-17.44%)

CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

C Citi
$63.41 /

-0.39 (-0.61%)

BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

BIG Big Lots
$46.79 /

+3.17 (+7.27%)

AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

ASAN Asana
$68.34 /

-22.82 (-25.03%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

Z Zillow
$57.99 /

+3.72 (+6.85%)

YEXT Yext
$10.09 /

+0.67 (+7.11%)

UPST Upstart
$171.90 /

-4.81 (-2.72%)

ULTA Ulta Beauty
$376.50 /

-6.74 (-1.76%)

TSLA Tesla
$1,014.85 /

-69.65 (-6.42%)

SPWR SunPower
$25.02 /

-1.89 (-7.02%)

REGN Regeneron
$627.00 /

-6.09 (-0.96%)

PTON Peloton
$42.57 /

-1.885 (-4.24%)

PFE Pfizer
$53.56 /

+0.54 (+1.02%)

NUE Nucor
$111.75 /

+4.49 (+4.19%)

MRVL Marvell
$83.53 /

+12.51 (+17.61%)

MRNA Moderna
$297.98 /

-3.48 (-1.15%)

MRK Merck
$73.51 /

-0.38 (-0.51%)

LLY Eli Lilly
$246.09 /

-1.83 (-0.74%)

JNJ Johnson & Johnson
$159.22 /

+2.105 (+1.34%)

FSLY Fastly
$35.95 /

-0.5 (-1.37%)

DOCU DocuSign
$140.82 /

-93.43 (-39.88%)

DIDI Didi
$6.44 /

-1.36 (-17.44%)

CS Credit Suisse
$9.58 /

-0.14 (-1.44%)

COO Cooper Companies
$391.03 /

+12.94 (+3.42%)

C Citi
$63.41 /

-0.39 (-0.61%)

BNTX BioNTech
$335.35 /

+2.57 (+0.77%)

BIG Big Lots
$46.79 /

+3.17 (+7.27%)

AZN AstraZeneca
$54.16 /

-0.62 (-1.13%)

ASAN Asana
$68.34 /

-22.82 (-25.03%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

AAPL Apple
$161.15 /

-2.65 (-1.62%)

Periodicals
FDA planning fast review of omicron vaccines and drugs, WSJ reports » 08:24
12/03/21
12/03
08:24
12/03/21
08:24
MRNA

Moderna

$301.46 /

-9.24 (-2.97%)

, PFE

Pfizer

$53.02 /

-1.65 (-3.02%)

, BNTX

BioNTech

$333.55 /

-1.09 (-0.33%)

, AZN

AstraZeneca

$54.78 /

-0.1 (-0.18%)

, JNJ

Johnson & Johnson

$157.08 /

-1.06 (-0.67%)

, MRK

Merck

$73.89 /

-0.54 (-0.73%)

, LLY

Eli Lilly

$247.84 /

-1.39 (-0.56%)

, REGN

Regeneron

$634.44 /

+2.08 (+0.33%)

The Food and Drug…

The Food and Drug Administration has been meeting with drugmakers and setting guidelines for the studies and data needed to quickly evaluate vaccines and drugs targeting the new omicron COVID-19 variant if they turn out to be needed, people familiar with the matter tell The Wall Street Journal's Felicia Schwartz. For vaccines, the companies wouldn't have to conduct large, lengthy trials enrolling thousands of subjects, but could study the immune responses in a few hundred subjects and would need about three months to develop and test the new vaccines, a person familiar with the matter told Schwartz. Makers of COVID-19 vaccines and therapeutics include Moderna (MRNA), Johnson & Johnson's (JNJ) Janssen, Pfizer (PFE), BioNTech (BNTX), Merck (MRK), Eli Lilly (LLY), Regeneron (REGN) and AstraZeneca (AZN). Reference Link

ShowHide Related Items >><<
REGN Regeneron
$634.44 /

+2.08 (+0.33%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
PFE Pfizer
$53.02 /

-1.65 (-3.02%)

11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

11/29/21 UBS
BioNTech to benefit if concerns about omicron variant increase, says UBS
11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
MRK Merck
$73.89 /

-0.54 (-0.73%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

11/30/21 Canaccord
Sigilon Therapeutics price target lowered to $12 from $23 at Canaccord
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/24/21 Truist
Eli Lilly price target raised to $301 from $262 at Truist
11/18/21 BMO Capital
Eli Lilly initiated with an Outperform at BMO Capital
REGN Regeneron
$634.44 /

+2.08 (+0.33%)

12/02/21 JonesTrading
Decibel Therapeutics initiated with a Buy at JonesTrading
11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
REGN Regeneron
$634.44 /

+2.08 (+0.33%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

REGN Regeneron
$634.44 /

+2.08 (+0.33%)

PFE Pfizer
$53.02 /

-1.65 (-3.02%)

MRNA Moderna
$301.46 /

-9.24 (-2.97%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

LLY Eli Lilly
$247.84 /

-1.39 (-0.56%)

JNJ Johnson & Johnson
$157.08 /

-1.06 (-0.67%)

BNTX BioNTech
$333.55 /

-1.09 (-0.33%)

AZN AstraZeneca
$54.78 /

-0.1 (-0.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.